Polus
Incheon
About Polus
Polus is a biopharmaceutical company specializing in solutions for medical equality. It provides therapeutic protein-based biosimilar products using large scales cell-culture technology to carry out global commercialization. The company's mission to transform the paradigm of the biopharmaceutical industry standards by making high-quality biological drugs at an affordable price for all patients in the world. Polus was founded in 2016 and is headquartered in Incheon, Inch'on-jikhalsi, South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $5.9M
- Last round: Series Unknown (Dec 2016)
- Website: polus-global.compolus
- Phone: 032-728-1000
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/polus-181762 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.